Octopus Biosafety Stock: price and insider trades · France
No insider purchase over the last 90 days. The latest, by Bertrand VERGNE, was filed 23 Jul 2024.
Octopus Biosafety: what insiders have been doing
Every trade that managers of Octopus Biosafety disclose to AMF is tracked on this page. The company sits in the Healthcare & Pharma sector. Nothing new has been filed by managers of Octopus Biosafety in twelve months, the latest record being from 23 July 2024.
Over the whole record (from 2023), the tally stands at 4 purchases and 19 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +317.9%Entry €0.11 · Close at T+365 €0.47
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2024FY ended December 2024 · cache
- 30,000 shares@ €0.70100.0% of flowActionEuronext Access ParisISIN FR00133102812024DD987523Canonical exit: 21 Oct 2024 (T+90)
- 1,500 shares@ €3.464.6% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T21
- 3 shares@ €0.270.0% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T22Canonical exit: 21 Oct 2024 (T+90)
- 1,000 shares@ €0.3740.3% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T23Canonical exit: 21 Oct 2024 (T+90)
- 33,000 shares@ €0.308.8% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T24Canonical exit: 26 Oct 2023 (T+90)
- 1,000 shares@ €3.703.3% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T18
- 1,000 shares@ €3.603.2% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T19
- 1,000 shares@ €3.543.2% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T20
- 7,002 shares@ €1.006.2% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T2
- 300 shares@ €3.801.0% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T3
- 1,000 shares@ €3.983.5% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T4
- 1,000 shares@ €3.503.1% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T5
- 1,000 shares@ €3.60153.2% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T6
- 2,000 shares@ €4.007.1% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T7
- 1,000 shares@ €3.603.2% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T8
- 500 shares@ €3.801.7% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T9
- 753 shares@ €4.002.7% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T10
- 2,000 shares@ €4.007.1% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T11
- 183 shares@ €4.000.7% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T12
- 1,000 shares@ €3.903.5% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T13
- 1,000 shares@ €3.903.5% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T14
- 1,000 shares@ €3.903.5% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T15
- 1,000 shares@ €3.903.5% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T16
- 1,264 shares@ €3.80184.3% of flowActionEuronext Access ParisISIN FR00133102812024DD987523-T17
- 2,196,584 shares@ €0.30100.0% of flowActionEuronext Access ParisISIN FR00133102812023DD922667
25 of 27 declarations
About Octopus Biosafety
OCTOPUS BIOSAFETY is a French robotics company focused primarily on poultry farming applications. Its core value proposition is to provide autonomous, intelligent and modular robots designed to improve animal welfare, biosecurity, farm productivity and working conditions while reducing the burden of repetitive, low-value tasks. The company was founded in 1987 and has built a long track record in robotic systems for agricultural and service environments. It is listed on Euronext Access Paris under ISIN FR0013310281.
The company’s product portfolio is centered on the XO robot, its flagship poultry solution. XO is designed to operate inside poultry houses, supporting litter management, flock stimulation and overall farm performance. OCTOPUS also markets T-Moov, stemming from the former TIBOT Technologies activity, as well as the Easy-LIT electric scarifier. Across these products, the strategic aim is consistent: automate recurring tasks, enhance hygiene and animal welfare, and deliver practical tools that help farmers improve technical and economic performance.
Read moreShow less
A major step in the company’s development was the acquisition of TIBOT Technologies’ assets in 2022, which strengthened OCTOPUS BIOSAFETY’s expertise and broadened its installed base. More recently, the company has undergone significant corporate and financial restructuring. In July 2025, the Commercial Court of Lorient approved a restructuring plan, and the company subsequently announced a strategic alignment with The Autonomous Way (TAW), a U.S. group specialized in the robotization of facility management. Public disclosures indicate that OCTOPUS is now a subsidiary of TAW, suggesting industrial, technological and commercial synergies ahead.
From a market standpoint, OCTOPUS BIOSAFETY is a niche player, but one with a differentiated technological profile in poultry robotics. Its solutions are positioned at the crossroads of agricultural automation and precision farming, with a clear emphasis on animal health, operational efficiency and data-driven management. The company has also been expanding its international footprint: XO was commercialized in France first and later abroad, and in 2025 OCTOPUS announced its first contract in Saudi Arabia with Tanmiah Food Company, one of the leading food groups in the region. Partnerships announced with EXCELCAR and the integration of industrial 5G into its robots further underline its ambition to industrialize and modernize its offering.
Overall, OCTOPUS BIOSAFETY stands out as a specialized robotics company with strong expertise in animal-farming applications, an innovation-led product pipeline, and a strategy that increasingly combines agriculture, autonomous robotics and artificial intelligence. Its challenge is now to convert this technological differentiation into scalable commercial growth, both in France and in selected export markets.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
